Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial.
Farnier M, Jones P, Severance R, Averna M, Steinhagen-Thiessen E, Colhoun HM, Du Y, Hanotin C, Donahue S. Farnier M, et al. Among authors: jones p. Atherosclerosis. 2016 Jan;244:138-46. doi: 10.1016/j.atherosclerosis.2015.11.010. Epub 2015 Nov 14. Atherosclerosis. 2016. PMID: 26638010 Free article. Clinical Trial.
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.
Gylling H, Plat J, Turley S, Ginsberg HN, Ellegård L, Jessup W, Jones PJ, Lütjohann D, Maerz W, Masana L, Silbernagel G, Staels B, Borén J, Catapano AL, De Backer G, Deanfield J, Descamps OS, Kovanen PT, Riccardi G, Tokgözoglu L, Chapman MJ; European Atherosclerosis Society Consensus Panel on Phytosterols. Gylling H, et al. Atherosclerosis. 2014 Feb;232(2):346-60. doi: 10.1016/j.atherosclerosis.2013.11.043. Epub 2013 Nov 23. Atherosclerosis. 2014. PMID: 24468148 Free article. Review.
The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
Ray KK, Ditmarsch M, Kallend D, Niesor EJ, Suchankova G, Upmanyu R, Anzures-Cabrera J, Lehnert V, Pauly-Evers M, Holme I, Štásek J, van Hessen MW, Jones P; dal-ACUTE Investigators. Ray KK, et al. Among authors: jones p. Eur Heart J. 2014 Jul 14;35(27):1792-800. doi: 10.1093/eurheartj/ehu105. Epub 2014 Mar 17. Eur Heart J. 2014. PMID: 24639426 Clinical Trial.
Dietary intervention to lower serum cholesterol.
Clifton P, Colquhoun D, Hewat C, Jones P, Litt J, Noakes M, O'Brien R, Shrapnel B, Skeaff M. Clifton P, et al. Among authors: jones p. Aust Fam Physician. 2009 Jun;38(6):424-9. Aust Fam Physician. 2009. PMID: 19521587
A Preoperative Risk Assessment Tool for Predicting Adverse Outcomes among Total Shoulder Arthroplasty Patients.
Avant-Garde Health and Codman Shoulder Society Value-Based Care Group.; Khan AZ, O'Donnell EA, Fedorka CJ, Kirsch JM, Simon JE, Zhang X, Liu HH, Abboud JA, Wagner ER, Best MJ, Armstrong AD, Warner JJP, Fares MY, Costouros JG, Woodmass J, da Silva Etges APB, Jones P, Haas DA, Gottschalk MB, Srikumaran U. Avant-Garde Health and Codman Shoulder Society Value-Based Care Group., et al. Among authors: jones p. J Shoulder Elbow Surg. 2024 Jun 3:S1058-2746(24)00397-5. doi: 10.1016/j.jse.2024.04.008. Online ahead of print. J Shoulder Elbow Surg. 2024. PMID: 38838843
8,668 results